|
|
|
|
|
|
|
UroGen Pharma Ltd. (URGN)
|
|
41.93 -0.33 (-0.78%)
|
10-19 16:00
|
|
Open:
|
42.42
|
Pre. Close:
|
42.26
|
|
High:
|
43.13
|
Low:
|
40.72
|
|
Volume:
|
44,651
|
Market Cap:
|
666M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
43.213 - 43.459
|
43.459 - 43.725
|
|
Low:
|
40.055 - 40.318
|
40.318 - 40.603
|
|
Close:
|
41.423 - 41.89
|
41.89 - 42.398
|
|
|
|
Technical analysis (as of: 2018-10-19 4:40:11 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 54.26 One year: 58.40
|
|
Support:
|
Support1: 40.72 Support2: 33.88
|
|
Resistance:
|
Resistance1:
46.46 Resistance2: 50.00
|
|
Pivot:
|
44.79
|
|
Moving Averages:
|
MA(5): 43.17 MA(20): 45.67
MA(100): 48.22 MA(250): 48.60 
|
|
MACD:
|
MACD(12,26):
-1.03 Signal(12,26,9): -0.62
|
|
%K %D:
|
%K(14,3): 20.37 %D(3): 24.07
|
|
RSI:
|
RSI(14): 38.90
|
|
52-Week:
|
High: 69.568
Low: 25.557 Change(%): 53.4
|
|
Average Vol(K):
|
3-Month: 6180
10-Days 6193
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.URGN has closed above bottom band by 17.2%. Bollinger Bands are 23.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-09-25T08:00:00-04:00
UroGen Pharma: Interesting Interim Data, Look Out For Top Line Data
2018-09-25T08:00:00-04:00
UroGen Pharma to Present at the Ladenburg Thalmann 2018 Healthcare Conference
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
